Abstract
In relapsing–remitting multiple sclerosis (RRMS), relapse severity and residual disability are difficult to predict. Nevertheless, this information is crucial both for guiding relapse treatment strategies and for informing patients.
Type
Publication
Journal of Neurology
Arthur Chatton
Postdoctoral researcher in Biostatistics
My research interests include causal inference, prediction and simulation studies.